Atrial Fibrillation Trial, Recruiting NCT06735001 Sponsor: University Hospital, Bordeaux Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT06735001
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older, of any gender or ethnic background
  • People who have given their free, informed, and written agreement to take part
  • People who are covered by, or benefit from, a social security scheme

Who may not be able to join:

  • People under the age of 18
  • People who have not given informed consent to participate
  • Women who are currently pregnant (the trial requires a pregnancy test, use of contraception, or confirmation of menopause for women in the control group)
  • People who are under administrative or judicial protection (for example, those under legal guardianship)
  • People who currently have, or have had within the last 3 months, an infection or inflammation of the heart or its surrounding lining (endocarditis or pericarditis)
  • People with an active tumour, whether non-cancerous or cancerous
  • People with a long-term inflammatory condition or a disease where the immune system attacks the body (such as an autoimmune disease)
  • People with a long-term liver disease
  • People who have had a heart attack within the last 8 weeks

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Nicolas DERVAL, University Hospital, Bordeaux

Phone: +33 5 35 38 19 58

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
10 March 2025
Est. completion
1 October 2029

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Biomarkers T1; Biomarkers T2; Biomarkers 2

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov